approved EB-2 (NIW)
Others
Research And Development · Nepal · 2025-01-25
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Proposed Endeavor
The petitioner proposes to develop gene therapy tools to better understand the molecular and genetic mechanisms driving neurological and neurodegenerative diseases, such as autism and Alzheimer’s. His work focuses on identifying novel therapeutic targets and disease-modifying agents using innovative molecular techniques to investigate brain and vascular function.
Why This Petition Was Approved
The petition was approved based on the petitioner's Ph.D. in cell and molecular biology and a record of 3 peer-reviewed journal articles, 1 conference abstract, and 2 preprints which garnered 19 citations. The case was supported by four expert recommendation letters and evidence of research funding from the National Institutes of Health (NIH) and the U.S. Department of Defense (DoD), satisfying all three Dhanasar prongs.
Similar Cases
Software Engineer
Artificial Intelligence · India
WeGreened EB-2 (NIW) approved
California 111 days 2026-12-13
The petitioner proposes to develop AI-driven activity monitoring methods for quality assurance in large-scale digital systems. The work focuses on identifying risks earlier and improving reliability to reduce costly disruptions across complex software platforms.
Management Consultant
Information Technology
WeGreened EB-2 (NIW) approved
2026-03-15
The petitioner proposes to continue their work in enterprise technology transformation, governance, and large-scale operational strategy. The work focuses on enhancing enterprise resilience, cybersecurity alignment, and digital transformation within major organizations to improve high-stakes operational settings.
Researcher
Healthcare
WeGreened EB-2 (NIW) approved
3 days 2026-03-02
The petitioner proposes to combine advanced clinical training with research to improve minimally invasive and reconstructive approaches for complex facial and nerve injuries. The work focuses on reducing downstream functional impairment and the overall care burden for patients.
Others
Information Technology · China
WeGreened EB-2 (NIW) approved
317 days 2026-02-21
The petitioner proposes to develop advanced deep learning models to improve the understanding of structure-function relationships in large biomolecules. This work aims to enable more accurate target identification, better candidate design, and more efficient therapeutic optimization for complex diseases. The endeavor specifically targets bottlenecks in drug development to reduce the high failure rate and cost of new drug candidates.
Frequently Asked Questions
A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-25.
Browse all casesAt a Glance
Outcome approved
Processing 64 days
EB-2 (NIW) Case Data
Scraped Case Data
Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist